Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xuchang Pharmaceutical
Xuchang, Henan, China
- Ownership
- Private
- Development stage
- Other
01
Overview
The company produces generic APIs and formulations, with original development of manidipine hydrochloride APIs and tablets, including the first domestic imitation in China, and products have passed GMP certification. No proprietary clinical drug results; products are commercial generics.
- Therapeutic areas
- NephrologyCardiovascularPsychiatry
- Modalities
- Small moleculePharmaceutical intermediateSolid preparation
- Industry
- Contract Manufacturing Organization
02
Partnerships
Academic collaborations with China Medicine University, University of Science and Technology Beijing, Zhengzhou UniversityIndustry collaboration with Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Beyond the preview
Go deeper on Xuchang Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xuchang Pharmaceutical.